J&J Will Deliver 3.9M Vaccine Doses Within 48 Hours, CEO Says

The transcript discusses the distribution and manufacturing of a vaccine, highlighting the availability of four million doses from a Dutch facility and addressing potential manufacturing issues in Baltimore. It outlines the production goals, including 100 million doses by June and nearly two billion by 2022. The text emphasizes the importance of scaling manufacturing facilities and partnerships with the US government and other pharmaceutical companies to enhance production capacity.

What has been done to scale up the manufacturing facilities?

What role does partnership play in the vaccine production process?